#Ep 5: The Consistent Compounders Show :Stay tuned to catch Saurabh Mukherjea in conversation with Sohini Andani, Fund Manager, SBI Mutual Fund.
you are here: HomeNewsIndia

India records 13,052 new COVID-19 cases, 127 fatalities

According to the ICMR, 19,65,88,372 samples have been tested up to January 30 with 7,50,964 samples being tested on Saturday.

January 31, 2021 / 12:28 PM IST

With 13,052 new coronavirus cases, India's COVID-19 tally has climbed to 1,07,46,183, while the number of people who have recuperated from the disease has surged to 1,04,23,125, according to the Union Health Ministry data updated on Sunday.

The national recovery rate has climbed to 96.99 percent.

The death toll increased to 1,54,274 with 127 new fatalities, the data updated at 8 am showed.

The number of people who have recuperated from the disease surged to 1,04,23,125. The COVID-19 case fatality rate stands at 1.44 percent.

The total COVID-19 active cases remained below 2 lakh for the 12th consecutive day.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

There are 1,68,784 active cases of coronavirus infections in the country which comprises 1.57 percent of the total caseload, the data stated.

India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16. It went past  60 lakh on September 28,  70 lakh on October 11, crossed 80 lakh on October 29,  90 lakh on November 20 and surpassed the one-crore mark on December 19.

According to the ICMR, 19,65,88,372 samples have been tested up to January 30 with 7,50,964  samples being tested on Saturday.

The 127 new fatalities include 42 from Maharashtra, 18 from Kerala, 9 each from Chhattisgarh and West Bengal, 8 each from  Delhi and Punjab.

A total of  1,54,274 deaths have been reported so far in the country including 51,042 from Maharashtra followed by 12,350 from Tamil Nadu, 12,213 from Karnataka, 10,849 from Delhi, 10,164 from West Bengal, 8,650 from Uttar Pradesh and, 7,153 from Andhra Pradesh.

The health ministry stressed that more than 70 percent of the deaths occurred due to comorbidities.

"Our figures are being reconciled with the Indian Council of  Medical Research," the ministry said on its website, adding that state-wise distribution of figures is subject to further verification and reconciliation.
PTI
first published: Jan 31, 2021 12:27 pm

stay updated

Get Daily News on your Browser
Sections